Human Immunodeficiency Virus Type 1 Protease Cleavage Site Mutations Associated with Protease Inhibitor Cross-Resistance Selected by Indinavir, Ritonavir, and/or Saquinavir

We examined the prevalence of cleavage site mutations, both within and outside the gag region, in 28 protease inhibitor (PI) cross-resistant patients treated with indinavir, ritonavir, and/or saquinavir compared to control patients treated with reverse transcriptase inhibitors. Three human immunodef...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Côté, Hélène C. F., Brumme, Zabrina L., Harrigan, P. Richard
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC113954/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11134271/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.2.589-594.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!